ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
9.61
0.00 (0.00%)
Sep 17, 2026, 9:35 AM EDT - Market open
ImmuCell Employees
ImmuCell had 73 employees as of December 31, 2025. The number of employees decreased by 2 or -2.67% compared to the previous year.
Employees
73
Change
-2
Growth
-2.67%
Revenue / Employee
$420,213
Profits / Employee
$10,786
Market Cap
87.28M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Adicet Bio | 102 |
| Fractyl Health | 100 |
| Fortress Biotech | 78 |
| Nutriband | 13 |
| MAIA Biotechnology | 13 |
| Rallybio | 7 |
| Aldeyra Therapeutics | 6 |
| NeOnc Technologies Holdings | 5 |
ICCC News
- 4 weeks ago - ImmuCell Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - ImmuCell Earnings release: Q2 2026 - Filings
- 4 weeks ago - ImmuCell Quarterly report: Q2 2026 - Filings
- 4 weeks ago - ImmuCell Slides: Q2 2026 - Filings
- 4 weeks ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026 - GlobeNewsWire
- 5 weeks ago - ImmuCell Slides: Investor presentation - Filings
- 5 weeks ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026 - GlobeNewsWire
- 2 months ago - Immucell reports preliminary Q2 revenue $7.2M - TheFly